Specializes in the use of Intensity Modulated Radiation Therapy (IMRT) and High Dose Rate Brachytherapy for treating various cancer types and uses radioisotope therapy, including Radium-223 (Xofigo) for prostate cancer. He also has a particular interest in enrolling patients on the latest clinical research trials.